12:00 AM
 | 
Apr 05, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Nuvigil armodafinil regulatory update

FDA issued a complete response letter for an sNDA from Cephalon for Nuvigil armodafinil to treat excessive sleepiness associated with jet lag disorder from eastbound travel. The company said the...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >